Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

Clinical trial NCT02996916 · UNKNOWN

Trial details

NCT number: NCT02996916
Sponsor: Kurume University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension

Start date: 2015-12-01
Primary completion: 2018-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.